Phase 1 Dose Escalation Study of the Rapidly Switchable Universal CAR-T Therapy Unicar-T-CD123 in Relapsed/Refractory AML
暂无分享,去创建一个
W. Fiedler | G. Ehninger | M. Wermke | M. von Bonin | S. Metzelder | M. Cartellieri | J. Middeke | S. Kraus | J. Schäfer | A. Ehninger | M. Goebeler | C. Kreissig | J. Koedam | Elisa Sala | V. Vučinić